“Tafero EM 200/25 mg Pharmaceutical” has been added to your cart. View cart
£14.00
Additional information
| Raw Material | Lacidipine |
|---|---|
| Water Retention | Possible, as peripheral edema |
| Hepatotoxicity | Low risk |
| Lab Test | Not specific |
| Also known as | Lercanidipine hydrochloride |
| Blood pressure | Reduces systolic and diastolic blood pressure |
| Trade name | Zanidip, Carmen |
| Storage conditions | Store at room temperature away from light and moisture |
| Chemical name | 2-[(3,3-Diphenylpropyl)(methyl)amino]-1,1-dimethylpropyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate |
| Formula | C36H41N3O6 |
| Substance class | Calcium channel blocker |
| Main action | Vasodilator |
| Half-life | 8-10 hours |
| Dosage (medical) | 10 mg or 20 mg once daily |
| Dosage (sports) | Not applicable |
| Effects | Lowering blood pressure, reducing strain on the heart |
| Side effects | Dizziness, headache, flushing, edema, fatigue, palpitations, gastrointestinal disturbances |
| Use in sports | Not typically used |
| Manufacturer | GlaxoSmithKLline |
| Packing | 1 x 28 tabs (4 mg/tab) |
